Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.75B |
| 2 |
Walmart Inc
WMT
|
+$3.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
Broadcom
AVGO
|
+$943M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$785M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
NVIDIA
NVDA
|
+$566M |
| 3 |
Apple
AAPL
|
+$554M |
| 4 |
AbbVie
ABBV
|
+$455M |
| 5 |
Bank of America
BAC
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.24% |
| 2 | Technology | 9.52% |
| 3 | Healthcare | 7.46% |
| 4 | Financials | 6.74% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
CALL
Unilever
UL
$140B
| $4.03M | ﹤0.01% |
61,600
+31,289
| +103% | +$2.1M |
|
|
IRD
3152
Opus Genetics
IRD
$307M
| $4.03M | ﹤0.01% |
+2,002,550
| New | +$4.07M |
|
3153
Preformed Line Products
PLPC
$1.98B
| $4.02M | ﹤0.01% |
19,470
+14,647
| +304% | +$3.12M |
|
3154
Arcus Biosciences
RCUS
$3.72B
| $4.02M | ﹤0.01% |
168,876
-466,068
| -73% | -$9.51M |
|
|
GAP
3155
PUT
The Gap Inc
GAP
$8.45B
| $4.02M | ﹤0.01% |
156,900
-22,900
| -13% | -$555K |
|
3156
HNI Corp
HNI
$3.55B
| $4.02M | ﹤0.01% |
95,524
-115,234
| -55% | -$4.87M |
|
3157
Protara Therapeutics
TARA
$226M
| $4.02M | ﹤0.01% |
753,302
+65,046
| +9% | +$362K |
|
|
SLN
3158
Silence Therapeutics
SLN
$834M
| $4.01M | ﹤0.01% |
659,592
+361,080
| +121% | +$2.31M |
|
|
VHCPU
3159
Vine Hill Capital Investment Corp II Units
VHCPU
| $4.01M | ﹤0.01% |
+400,000
| New | +$4.01M |
|
3160
Sprott Uranium Miners ETF
URNM
$2.1B
| $4.01M | ﹤0.01% |
73,007
+11,719
| +19% | +$677K |
|
|
MESHU
3161
Meshflow Acquisition Corp Units
MESHU
$305M
| $4M | ﹤0.01% |
+400,000
| New | +$4M |
|
|
SCPQU
3162
Social Commerce Partners Corp Unit
SCPQU
$106M
| $4M | ﹤0.01% |
+400,000
| New | +$4.01M |
|
3163
Janux Therapeutics
JANX
$1.1B
| $4M | ﹤0.01% |
289,808
+189,163
| +188% | +$4.45M |
|
|
AEAQU
3164
Activate Energy Acquisition Corp Unit
AEAQU
$211M
| $4M | ﹤0.01% |
+400,000
| New | +$4M |
|
3165
Insteel Industries
IIIN
$590M
| $4M | ﹤0.01% |
126,195
-28,427
| -18% | -$928K |
|
3166
Peapack-Gladstone Financial
PGC
$800M
| $3.99M | ﹤0.01% |
143,306
+71,932
| +101% | +$1.96M |
|
3167
StoneX
SNEX
$8.28B
| $3.99M | ﹤0.01% |
+94,361
| New | +$3.95M |
|
3168
Quince Therapeutics
QNCX
$34.3M
| $3.99M | ﹤0.01% |
5,952
-982
| -14% | -$494K |
|
3169
Ameresco
AMRC
$1.17B
| $3.99M | ﹤0.01% |
136,089
+84,542
| +164% | +$2.97M |
|
|
TWLVU
3170
Twelve Seas Investment Company III Units
TWLVU
| $3.98M | ﹤0.01% |
+400,000
| New | +$3.99M |
|
3171
America Movil
AMX
$69.4B
| $3.97M | ﹤0.01% |
192,219
+154,588
| +411% | +$3.4M |
|
3172
PUT
JB Hunt Transport Services
JBHT
$24.5B
| $3.96M | ﹤0.01% |
20,400
+9,400
| +85% | +$1.61M |
|
3173
Woori Financial
WF
$17.8B
| $3.95M | ﹤0.01% |
+67,254
| New | +$3.75M |
|
3174
Riskified
RSKD
$833M
| $3.95M | ﹤0.01% |
795,441
+612,719
| +335% | +$2.95M |
|
3175
Lemonade
LMND
$4.1B
| $3.95M | ﹤0.01% |
55,508
-118,798
| -68% | -$7.98M |
|
Similar funds
Israel Englander's Q4 2025 Portfolio in Review
As of Q4 2025, Israel Englander held 6,645 positions worth $238B, up 1.5% from $234B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Israel Englander's Q4 2025 filing shows 668 new, 2,203 increased, 2,701 reduced and 696 closed positions. Its largest new stake was iShares Russell 1000 ETF: 455,129 shares worth $170M. The largest sale was Microsoft, an estimated $572M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2025 buy was iShares Russell 1000 ETF: 455,129 shares worth $170M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $4.75B increase.
- Israel Englander's biggest Q4 2025 reduction was Microsoft, cutting an estimated $572M.
- Israel Englander fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Israel Englander's ten largest holdings make up 19% of its $238B portfolio in Q4 2025.
- Israel Englander opened 668 new positions and closed 696 in Q4 2025.
- Israel Englander's portfolio value rose 1.5% quarter-over-quarter to $238B.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.